Education
About Us
Working with TipRanks
Follow Us
Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 67.42M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 67.42M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -191.19M | $ -299.51M | $ -227.29M | $ -216.54M | $ -118.79M |
| EBITDA | $ -186.17M | $ -247.60M | $ -225.86M | $ -207.20M | $ -118.63M |
| Net Income | $ -165.84M | $ -292.19M | $ -236.81M | $ -158.72M | $ -117.84M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 371.08M | $ 482.92M | $ 437.37M | $ 340.13M | $ 338.50M |
| Total Assets | $ 430.34M | $ 562.03M | $ 553.46M | $ 472.02M | $ 365.56M |
| Total Debt | $ 42.65M | $ 45.77M | $ 47.33M | $ 45.91M | $ 2.00M |
| Net Debt | $ 8.75M | $ 17.73M | $ 4.26M | $ -14.04M | $ -52.95M |
| Total Liabilities | $ 93.15M | $ 124.64M | $ 119.43M | $ 107.54M | $ 32.18M |
| Stockholders' Equity | $ 337.19M | $ 437.28M | $ 433.80M | $ 363.95M | $ 308.58M |
| Cash Flow | |||||
| Free Cash Flow | $ -171.08M | $ -208.41M | $ -166.30M | $ -160.20M | $ -87.58M |
| Operating Cash Flow | $ -170.86M | $ -207.82M | $ -163.75M | $ -154.09M | $ -86.83M |
| Investing Cash Flow | $ 176.56M | $ -44.46M | $ -114.18M | $ -18.11M | $ -284.83M |
| Financing Cash Flow | $ 108.00K | $ 237.30M | $ 261.04M | $ 178.52M | $ 360.44M |
Zentalis Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.